{
    "organizations": [],
    "uuid": "3455705cda76badd5f19c895c3475bd88ddbcf6b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-basilea-starts-clinical-phase-1-st/brief-basilea-starts-clinical-phase-1-study-in-collaboration-with-u-s-adult-brain-tumor-consortium-idUSFWN1OX0Q2",
    "ord_in_thread": 0,
    "title": "BRIEF-Basilea starts clinical phase 1 study in collaboration with U.S. Adult Brain Tumor Consortium ​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 3, 2018 / 6:22 AM / Updated 9 minutes ago BRIEF-Basilea starts clinical phase 1 study in collaboration with U.S. Adult Brain Tumor Consortium ​ Reuters Staff 1   Basilea Pharmaceutica Ag: \n* ‍INITIATION OF A PHASE 1 STUDY CONDUCTED UNDER ITS CLINICAL STUDY AGREEMENT WITH ADULT BRAIN TUMOR CONSORTIUM IN U.S.​ \n* ‍BASILEA EXPECTS TO COMPLETE PHASE 1 PATIENT RECRUITMENT INTO SEPARATE GLIOBLASTOMA ARM OF ORAL STUDY IN FIRST HALF OF 2018​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T08:20:00.000+02:00",
    "crawled": "2018-01-03T08:34:35.035+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "updated",
        "minute",
        "ago",
        "start",
        "clinical",
        "phase",
        "study",
        "collaboration",
        "adult",
        "brain",
        "tumor",
        "consortium",
        "reuters",
        "staff",
        "basilea",
        "pharmaceutica",
        "ag",
        "phase",
        "study",
        "conducted",
        "clinical",
        "study",
        "agreement",
        "adult",
        "brain",
        "tumor",
        "consortium",
        "expects",
        "complete",
        "phase",
        "patient",
        "recruitment",
        "separate",
        "glioblastoma",
        "arm",
        "oral",
        "study",
        "first",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}